BACKGROUND: Acyl-ghrelin is thought to have both orexigenic effects and to stimulate GH release. A possible cause of the anorexia of aging is an age-dependent decrease in circulating acyl-ghrelin levels. OBJECTIVES: The purpose of the study was to compare acyl-ghrelin and GH concentrations between healthy old and young adults and to examine the relationship of acyl-ghrelin and GH secretion in both age groups. METHODS: Six healthy older adults (age 62-74 y, body mass index range 20.9-29 kg/m(2)) and eight healthy young men (aged 18-28 y, body mass index range 20.6-26.2 kg/m(2)) had frequent blood samples drawn for hormone measurements every 10 minutes for 24 hours. Ghrelin was measured in an in-house, two-site sandwich ELISA specific for full-length acyl-ghrelin. GH was measured in a sensitive assay (Immulite 2000), and GH peaks were determined by deconvolution analysis. The acyl-ghrelin/GH association was estimated from correlations between amplitudes of individual GH secretory events and the average acyl-ghrelin concentration in the 60-minute interval preceding each GH burst. RESULTS: Twenty-four-hour mean (±SEM) GH (0.48 ± 0.14 vs 2.2 ± 0.3 μg/L, P < .005) and acyl-ghrelin (14.7 ± 2.3 vs 27.8 ± 3.9 pg/mL, P < .05) levels were significantly lower in older adults compared with young adults. Twenty-four-hour cortisol concentrations were higher in the old than the young adults (15.1 ± 1.0 vs 10.6 ± 0.9 μg/dL, respectively, P < .01). The ghrelin/GH association was more than 3-fold lower in the older group compared with the young adults (0.16 ± 0.12 vs 0.69 ± 0.04, P < .001). CONCLUSIONS: These results provide further evidence of an age-dependent decline in circulating acyl-ghrelin levels, which might play a role both in the decline of GH and in the anorexia of aging. Our data also suggest that with normal aging, endogenous acyl-ghrelin levels are less tightly linked to GH regulation.
BACKGROUND:Acyl-ghrelin is thought to have both orexigenic effects and to stimulate GH release. A possible cause of the anorexia of aging is an age-dependent decrease in circulating acyl-ghrelin levels. OBJECTIVES: The purpose of the study was to compare acyl-ghrelin and GH concentrations between healthy old and young adults and to examine the relationship of acyl-ghrelin and GH secretion in both age groups. METHODS: Six healthy older adults (age 62-74 y, body mass index range 20.9-29 kg/m(2)) and eight healthy young men (aged 18-28 y, body mass index range 20.6-26.2 kg/m(2)) had frequent blood samples drawn for hormone measurements every 10 minutes for 24 hours. Ghrelin was measured in an in-house, two-site sandwich ELISA specific for full-length acyl-ghrelin. GH was measured in a sensitive assay (Immulite 2000), and GH peaks were determined by deconvolution analysis. The acyl-ghrelin/GH association was estimated from correlations between amplitudes of individual GH secretory events and the average acyl-ghrelin concentration in the 60-minute interval preceding each GH burst. RESULTS: Twenty-four-hour mean (±SEM) GH (0.48 ± 0.14 vs 2.2 ± 0.3 μg/L, P < .005) and acyl-ghrelin (14.7 ± 2.3 vs 27.8 ± 3.9 pg/mL, P < .05) levels were significantly lower in older adults compared with young adults. Twenty-four-hour cortisol concentrations were higher in the old than the young adults (15.1 ± 1.0 vs 10.6 ± 0.9 μg/dL, respectively, P < .01). The ghrelin/GH association was more than 3-fold lower in the older group compared with the young adults (0.16 ± 0.12 vs 0.69 ± 0.04, P < .001). CONCLUSIONS: These results provide further evidence of an age-dependent decline in circulating acyl-ghrelin levels, which might play a role both in the decline of GH and in the anorexia of aging. Our data also suggest that with normal aging, endogenous acyl-ghrelin levels are less tightly linked to GH regulation.
Authors: A Katz; S S Nambi; K Mather; A D Baron; D A Follmann; G Sullivan; M J Quon Journal: J Clin Endocrinol Metab Date: 2000-07 Impact factor: 5.958
Authors: A E Rigamonti; A I Pincelli; B Corrà; R Viarengo; S M Bonomo; D Galimberti; M Scacchi; E Scarpini; F Cavagnini; E E Müller Journal: J Endocrinol Date: 2002-10 Impact factor: 4.286
Authors: Ralf Nass; Jianhua Liu; James Patrie; Suzan S Pezzoli; Leon S Farhy; Bruce D Gaylinn; Michael O Thorner Journal: J Clin Endocrinol Metab Date: 2014-06-25 Impact factor: 5.958
Authors: Kerstin Sturm; Caroline G MacIntosh; Barbara A Parker; Judith Wishart; Michael Horowitz; Ian M Chapman Journal: J Clin Endocrinol Metab Date: 2003-08 Impact factor: 5.958
Authors: Christian Anderwald; Georg Brabant; Elisabeth Bernroider; Rüdiger Horn; Attila Brehm; Werner Waldhäusl; Michael Roden Journal: Diabetes Date: 2003-07 Impact factor: 9.461
Authors: Kara C Anderson; Gabriel Zieff; Craig Paterson; Lee Stoner; Arthur Weltman; Jason D Allen Journal: Peptides Date: 2021-08-12 Impact factor: 3.867
Authors: Nicole H Rogers; Heidi Walsh; Oscar Alvarez-Garcia; Seongjoon Park; Bruce Gaylinn; Michael O Thorner; Roy G Smith Journal: Endocrinology Date: 2016-01-26 Impact factor: 4.736
Authors: Lara Pena-Bello; Sonia Pertega-Diaz; Elena Outeiriño-Blanco; Jesus Garcia-Buela; Sulay Tovar; Susana Sangiao-Alvarellos; Carlos Dieguez; Fernando Cordido Journal: PLoS One Date: 2015-03-17 Impact factor: 3.240
Authors: Behiye Özcan; Patric J D Delhanty; Martin Huisman; Jenny A Visser; Sebastian J Neggers; Aart Jan van der Lely Journal: Diabetol Metab Syndr Date: 2021-07-22 Impact factor: 3.320
Authors: Barbora Hucik; Andrew J Lovell; Evan M Hoecht; Daniel T Cervone; David M Mutch; David J Dyck Journal: Adipocyte Date: 2021-12 Impact factor: 4.534